Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 CzIPN. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120965536A enables mild photoredox synthesis. Offers supply chain reliability and cost reduction for high-purity pharmaceutical intermediates manufacturing.
Novel visible-light method using 4CzIPN for high-purity sulfone intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Patent CN114075108A details a metal-free visible light method for aldehyde deuteration, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN110963900A details a metal-free oxidative decarboxylation method using 4CzIPN and air, offering a green route for high-purity pharmaceutical intermediates manufacturing.
Novel blue-light mediated method for ((alkylamino)methyl)diphenylphosphine oxides. Mild conditions, high purity, scalable process for pharma intermediates.
Patent CN115448816A reveals a mild, visible-light driven route for beta-fluoroalkenyl alcohols, offering safer manufacturing and cost reduction for pharma intermediates.
Patent CN116462636B reveals green visible light synthesis for quinoxalinone derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115232159A reveals a novel photoredox C-H borylation method. Enables cost reduction in pharmaceutical intermediate manufacturing with high regioselectivity.
Patent CN114805209A details a metal-free photocatalytic route for 3-aryl-2H-indazoles using aryl sulfonium salts, offering cost reduction and supply chain reliability.